Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Teikoku Pharma USA is a specialty pharmaceutical company focused on developing and commercializing innovative transdermal drug delivery systems. As the U.S. subsidiary of Teikoku Seiyaku, the company leverages proprietary patch technologies to improve the delivery of established medications, particularly in pain management and CNS disorders. Their portfolio includes the widely recognized Lidoderm patch for post-herpetic neuralgia and Synera for local dermal analgesia. Teikoku Pharma USA continues to advance a pipeline of transdermal patches for indications such as Alzheimer's disease and Parkinson's disease. The company's expertise spans from formulation and clinical development to regulatory approval and commercial partnership.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Teikoku Pharma USA.